These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36690130)

  • 1. Paradigm of lyotropic liquid crystals in tissue regeneration.
    Shah S; Joga R; Kolipaka T; Sabnis Dushyantrao C; Khairnar P; Simran ; Phatale V; Pandey G; Srivastava S; Kumar S
    Int J Pharm; 2023 Mar; 634():122633. PubMed ID: 36690130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic lyotropic liquid crystals: Insights on biomedical applications.
    Blanco-Fernández G; Blanco-Fernandez B; Fernández-Ferreiro A; Otero-Espinar FJ
    Adv Colloid Interface Sci; 2023 Mar; 313():102867. PubMed ID: 36889183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubic and hexagonal liquid crystals as drug delivery systems.
    Chen Y; Ma P; Gui S
    Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in lyotropic liquid crystal systems for skin drug delivery.
    Silvestrini AVP; Caron AL; Viegas J; Praça FG; Bentley MVLB
    Expert Opin Drug Deliv; 2020 Dec; 17(12):1781-1805. PubMed ID: 32886531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
    Libster D; Aserin A; Garti N
    J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additives-directed lyotropic liquid crystals architecture: Simulations and experiments.
    Wang K; Li Z; Huang Y; YaotianTao ; Liang X; Chu X; He N; Gui S; Li Z
    Int J Pharm; 2021 May; 600():120353. PubMed ID: 33549811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluronic P123/DMSO Lyotropic Liquid Crystal for Incorporating Bioactive Substances for Topical Application.
    Selivanova NM; Galeeva AI; Ziganshin MA; Galyametdinov YG
    J Phys Chem B; 2024 May; 128(20):5127-5134. PubMed ID: 38736379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyotropic liquid crystals for parenteral drug delivery.
    Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
    J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembling in situ gel based on lyotropic liquid crystals containing VEGF for tissue regeneration.
    Wang B; Huang Y; Huang Z; Wang H; Chen J; Pan X; Wu C
    Acta Biomater; 2019 Nov; 99():84-99. PubMed ID: 31521813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan/Lactic Acid Systems: Liquid Crystalline Behavior, Rheological Properties, and Riboflavin Release In Vitro.
    Selivanova NM; Galeeva AI; Galyametdinov YG
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals.
    Dinh L; Yan B
    Liquids (Basel); 2023 Dec; 3(4):456-468. PubMed ID: 38711572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application.
    Mancuso A; Cianflone E; Cristiano MC; Salerno N; Tarsitano M; Marino F; Molinaro C; Fresta M; Torella D; Paolino D
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyotropic liquid crystalline phases from helical β-peptides as alignment media.
    Thiele CM; Pomerantz WC; Abbott NL; Gellman SH
    Chem Commun (Camb); 2011 Jan; 47(1):502-4. PubMed ID: 20972503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyotropic liquid crystal-based transcutaneous peptide delivery system: Evaluation of skin permeability and potential for transcutaneous vaccination.
    Kozaka S; Wakabayashi R; Kamiya N; Goto M
    Acta Biomater; 2022 Jan; 138():273-284. PubMed ID: 34774785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse lyotropic liquid crystals from europium nitrate and P123 with enhanced luminescence efficiency.
    Yi S; Li Q; Liu H; Chen X
    J Phys Chem B; 2014 Oct; 118(39):11581-90. PubMed ID: 25215923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
    Milak S; Zimmer A
    Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in versatile inverse lyotropic liquid crystals.
    Shan X; Luo L; Yu Z; You J
    J Control Release; 2022 Aug; 348():1-21. PubMed ID: 35636617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic and Reversible Polymorphism of Self-Assembled Lyotropic Liquid Crystalline Systems Derived from Cyclic Bis(ethynylhelicene) Oligomers.
    Saito N; Kanie K; Matsubara M; Muramatsu A; Yamaguchi M
    J Am Chem Soc; 2015 May; 137(20):6594-601. PubMed ID: 25939825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyotropic liquid crystalline phases of a phytosterol ethoxylate in amide solvents.
    Yue X; Chen X; Li Q; Li Z
    Langmuir; 2013 Sep; 29(35):11013-21. PubMed ID: 23968535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.